Closing the Generation Gap: Part 2 - Hemophilia Federation of America
Join us in a discussion as young adults and experienced members of the community share their knowledge with each other. This discussion is intended to “close the generation gap” and provide a space for community members, both younger and wiser, to share their perspectives and experiences with their bleeding disorder. Part 1 was a great […]
<!-- wp:paragraph --> <p>Join us in a discussion as young adults and experienced members of the community share their knowledge with each other. This discussion is intended to “close the generation gap” and provide a space for community members, both younger and wiser, to share their perspectives and experiences with their bleeding disorder.</p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>Part 1 was a great success, and we can't wait for you to join us for part 2. </p> <!-- /wp:paragraph -->
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Core Concepts - HIV in Infants and Children - Key Populations - National HIV Curriculum
The Next Big Thing in Health Reform: Where to Start? - The American Prospect
Haemophilia Nature Reviews Disease Primers
Cell and Gene Therapy Advancements, Challenges, and the Path to Commercial Success
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Upcoming Events — The Coalition for Hemophilia B
Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles
European Haemophilia Consortium (EHC)
Hemophilia Federation of America
National Haemophilia No 218 June 2022 by Haemophilia Foundation Australia - Issuu
Emicizumab offers 'new path forward' for infants with severe hemophilia A
WFH Global Forum 2009 proceedings - Home - World Federation of
NORD and the Galactosemia Foundation Jointly Publish First “Voice of the Patient” Report to Help Inform the FDA and Researchers - National Organization for Rare Disorders
